LAPORAN HASIL PENELITIAN PENGARUH EKSTRAK BUAH …eprints.umm.ac.id/39309/1/PENDAHULUAN.pdf ·...

14
LAPORAN HASIL PENELITIAN PENGARUH EKSTRAK BUAH CEPOKAK (Solanum torvum Swartz) TERHADAP KADAR MALONDIALDEHIDA (MDA) TIKUS PUTIH JANTAN (Rattus norvegicus strain Wistar) YANG DIINDUKSI ISONIAZID DAN RIFAMPISIN Oleh: JUNDI ABYAN 201410330311088 UNIVERSITAS MUHAMMADIYAH MALANG FAKULTAS KEDOKTERAN 2018

Transcript of LAPORAN HASIL PENELITIAN PENGARUH EKSTRAK BUAH …eprints.umm.ac.id/39309/1/PENDAHULUAN.pdf ·...

LAPORAN HASIL PENELITIAN

PENGARUH EKSTRAK BUAH CEPOKAK (Solanum torvum Swartz) TERHADAP

KADAR MALONDIALDEHIDA (MDA) TIKUS PUTIH JANTAN (Rattus norvegicus

strain Wistar) YANG DIINDUKSI

ISONIAZID DAN RIFAMPISIN

Oleh:

JUNDI ABYAN

201410330311088

UNIVERSITAS MUHAMMADIYAH MALANG

FAKULTAS KEDOKTERAN

2018

HASIL PENELITIAN

PENGARUH EKSTRAK BUAH CEPOKAK (Solanum torvum Swartz) TERHADAP

KADAR MDA TIKUS PUTIH JANTAN (Rattus norvegicus strain Wistar) YANG

DIINDUKSI

ISONIAZID DAN RIFAMPISIN

Diajukan kepada

Universitas Muhammadiyah Malang

untuk Memenuhi Salah Satu Persyaratan

dalam Menyelesaikan Program Sarjana

Fakultas Kedokteran

Oleh:

JUNDI ABYAN

201410330311088

UNIVERSITAS MUHAMMADIYAH MALANG

FAKULTAS KEDOKTERAN

2018

KATA PENGANTAR

Assalamu’alaikum Warahmatullahi Wabarakaatuh,

Puji syukur kepada Allah SWT yang senantiasa memberikan dan melimpahkan Rahmat serta

Ridha-Nya, sehingga penulisan tugas akhir dengan judul “Pengaruh Ekstrak Buah Cepokak

(Solanum torvum Swartz) Terhadap Kadar malondialdehida (MDA) Tikus Putih Jantan

(Rattus novergicus strain Wistar) yang diinduksi Isoniazid dan Rifampisin” dapat

terselesaikan. Begitu pula atas kehendakNya gerakan tangan serta pikiran dapat selaras dalam

penyelesaian karya tulis akhir ini.

Dalam penyelesaian tugas akhir ini penulis banyak mengalami kesulitan, tetapi berkat

dukungan, bimbingan, dan bantuan dari dosen pembimbing dalam rangka penyusunan dan

dorongan dari berbagai pihak akhirnya penulis dapat menyelesaikan tugas akhir ini.

Penulis menyadari bahwa penelitian ini masih jauh dari kata sempurna, karenanya kritik

dan saran yang membangun sangat diharapkan peneliti demi kesempurnaan penyusunan. Semoga

tugas akhir ini bermanfaat bagi semua pihak.

Wassalamu’alaikum Warahmatullahi Wabarakaatuh

Penulis

Malang, 6 Juni 2018

DAFTAR ISI halaman

HALAMAN JUDUL ...................................................................................................................... ii

LEMBAR PENGESAHAN ........................................................................................................... iii

PERNYATAAN ORISINALITAS ................................................................................................ iv

LEMBAR PENGUJIAN ..................................................................................................................v

KATA PENGANTAR ................................................................................................................... vi

UCAPAN TERIMAKASIH ......................................................................................................... vii

ABSTRAK .......................................................................................................................................x

ABSTRACT ................................................................................................................................... xi

DAFTAR ISI ................................................................................................................................. xii

DAFTAR GAMBAR ................................................................................................................... xvi

DAFTAR TABEL ....................................................................................................................... xvii

DAFTAR SINGKATAN ........................................................................................................... xviii

BAB 1 PENDAHULUAN ...............................................................................................................1

1.1 Latar Belakang ...............................................................................................................1

1.2 Rumusan Masalah ..........................................................................................................3

1.3 Tujuan Penelitian ...........................................................................................................3

1.3.1 Tujuan Umum .......................................................................................................3

1.3.2 Tujuan Khusus ......................................................................................................3

1.4 Manfaat Penelitian .........................................................................................................4

1.4.1 Manfaat Akademik................................................................................................4

1.4.2 Manfaat Klinis ......................................................................................................4

1.4.2 Manfaat Masyarakat..............................................................................................4

BAB 2 TINJAUAN PUSTAKA ......................................................................................................5

2.1 Hepar ..............................................................................................................................5

2.1.1 Anatomi Hepar ......................................................................................................5

2.1.2 Fisiologi Hepar......................................................................................................7

2.1.3 Histologi Hepar .....................................................................................................8

2.1.4 Metabolisme Obat di Hepar ..................................................................................9

2.1.5 Intoksikasi Hepar Akibat Obat (Drug-Induced Hepatotoxicity) .........................11

2.2 Tuberkulosis (TB) .......................................................................................................11

2.3 Isoniazid (INH) dan Rifampisin (RIF) .........................................................................12

2.3.1 Isoniazid (INH) ....................................................................................................12

2.3.2 Rifampisin (RIF) .................................................................................................13

2.4 Mekanisme Hepatotoksisitas INH dan RIF .................................................................14

2.5 Cepokak (Solanum torvum Swartz) ............................................................................15

2.5.1 Epidemiologi .......................................................................................................15

2.5.2 Taksonomi...........................................................................................................15

2.5.3 Morfologi ............................................................................................................16

2.5.4 Kandungan ..........................................................................................................17

2.5.4.1 Asam Gallat ...............................................................................................17

2.5.4.2 Flavonoid ...................................................................................................17

2.5.4.3 Saponin ......................................................................................................18

2.5.4.4 Tanin ..........................................................................................................18

2.6 Radikal Bebas, Stress Oksidatif, Malondialdehida (MDA) .........................................19

2.6.1 Radikal Bebas dan Stress Oksidatif ....................................................................19

2.6.2 Malondialdehida (MDA) ....................................................................................20

BAB 3 KERANGKA KONSEP DAN HIPOTESIS PENELITIAN .............................................24

3.1 Kerangka Konseptual Penelitian ..................................................................................24

3.2 Hipotesis Penelitian ....................................................................................................26

BAB 4 METODE PENELITIAN ..................................................................................................27

4.1 Jenis dan Rancangan Penelitian ...................................................................................27

4.2 Tempat dan Waktu Penelitian ......................................................................................27

4.3 Populasi dan Sampel Penelitian ...................................................................................27

4.3.1 Populasi ...............................................................................................................27

4.3.2 Sampel.................................................................................................................27

4.3.3 Besar sampel .......................................................................................................27

4.3.4 Teknik pengambilan sampel ...............................................................................28

4.3.5 Karakteristik sampel penelitian ...........................................................................29

4.3.5.1 Kriteria inklusi ........................................................................................29

4.3.5.2 Kriteria drop out .....................................................................................29

4.3.6 Variabel penelitian ..............................................................................................29

4.3.6.1 Variabel bebas .........................................................................................29

4.3.6.2 Variabel tergantung .................................................................................29

4.3.6.2 Variabel Perancu .....................................................................................30

4.3.7 Definisi operasional variabel ..............................................................................30

4.4 Alat dan Bahan Penelitian ............................................................................................31

4.4.1 Alat ......................................................................................................................31

4.4.2 Bahan ..................................................................................................................33

4.5 Prosedur Penelitian ......................................................................................................34

4.5.1 Tahap aklimatisasi dan pengelompokan tikus ....................................................34

4.5.1.1 Tahap aklimatisasi ..................................................................................35

4.5.1.2 Tahap pengelompokan tikus ...................................................................36

4.5.2 Pembuatan ekstrak buah cepokak (Solanum torvum Swartz) 37 4.5.3 Penentuan

dosis ekstrak buah cepokak (Solanum torvum S) ) .......................................................37

4.5.4 Penentuan dosis isoniazid dan rifampisin ............................................................37

4.6 Pelaksanaan Perlakuan Penelitian ................................................................................38

4.7 Tahap Pembedahan dan Pengukuran MDA .................................................................39

4.8 Penanganan Hewan Coba Setelah Pembedahan .........................................................40

4.9 Alur Penelitian .............................................................................................................41

4.10 Analisis Data ..............................................................................................................42

BAB 5 HASIL PENELITIAN DAN ANALISIS DATA ..............................................................44

5.1 Hasil Penelitian ............................................................................................................44

5.2 Analisis Data ................................................................................................................45

5.2.1 Uji Normalitas ......................................................................................................46

5.2.2 Uji Homogenitas ...................................................................................................47

5.2.3 Uji one way anova ................................................................................................47

5.2.4 Uji post hoc bonferroni ........................................................................................47

5.2.5 Uji Regresi Linear ................................................................................................48

BAB 6 PEMBAHASAN ................................................................................................................50

BAB 7 KESIMPULAN DAN SARAN .........................................................................................54

7.1 Kesimpulan ..................................................................................................................54

7.2 Saran ............................................................................................................................54

DAFTAR PUSTAKA ....................................................................................................................55

LAMPIRAN ...................................................................................................................................60

DAFTAR LAMPIRAN

Lampiran 1 : Surat Hasil dan Analisis Data...……………………………………………………Error! Bookmark not defined.

Lampiran 2 : Dokumentasi Penelitian ……………………………………………………………Error! Bookmark not defined.

Lampiran 3 : Surat Keterangan Laik Etik………………………………………………………..Error! Bookmark not defined.

Lampiran 4 : Surat Keterangan Selesai Penelitian……………………………………………… Error! Bookmark not defined.

Lampiran 5 : Surat Keterangan Lolos Kajian Ilmiah…………………………………………….Error! Bookmark not defined.

Lampiran 6 : Surat Determinasi Ekstrak Tanaman Cepokak…………………………………….Error! Bookmark not defined.

Lampiran 7 : Surat Konsultasi Bimbing……………...………………………………………. 72

DAFTAR PUSTAKA

Abdulkadir AR, Mat N, Hasan MM, Jahan MS, 2016, In Vitro Antioxidant Activity of The Ethanolic Extract from Fruit, Stem, and Leaf Solanum torvum, ScienceAsia 42, pp.184-189.

Andarwulan N, Dewi K, Riza AA, Hardianzah R, Anna VR, Bradley WB, 2012, Polyphenols,

Carotenoids, and Ascorbic Acid in Underutilized Medicinal Vegetables, J FunctFoods 4: pp. 339-347.

Anwar K, Triyasmono L, 2016, Kandungan Total Fenolik, Total Flavonoid, dan Aktivitas

Antioksidan Ekstrak Etanol Buah Mengkudu (Morina citrifolia L.), Jurnal Pharmascience, Vol 3, No. 1, hal: 83-92.

Ballcombe J.P., Neal D, and Chad, 2004, Laboratory Routine Cause Animal Stress, American Ascociation For Laboratory Animal Science, vol.43, pp. 24-40.

Basini J, Mohanalakshmi S, Anitha K, 2013, Antihepatotoxic Effect of Barleria montana Leaves Against Anti-TB Drugs Induced Hepatotoxicity, International Research Journal of Pharmacy, vol.4(6), pp. 97-101.

Bhuvaneswari B, Hari R, Vasuki R, Suguna, 2012, Antioxidant and Antihepatotoxic Activities of

Ethanolic Extract of Solanum torvum, Asian Journal of Pharmaceutical and Clinical Research, Vol 5, Suppl 3. Pp. 147-150.

Chambers HF, 2007, Antimycobacterium Drugs, in Katzung BG (ed.), Basic and Clinical

Pharmacology, 10th edn, McGraw-Hill, London-United Kingdom, pp. 771-780. Chen J, Raymond K, 2006, Roles of Rifampicin in Drug-Drug Interactions: Underlying Molecular

Mechanisms Involving The Nuclear Pregnane X Receptor, Annals of Clinical Microbiology and Antimicrobial, Vol.5 No.3, pp. 1-11.

Chris Tanto, Frans Liwang, Sonia Hanifati, Eka Adip Pradipta, 2014, Kapita Selekta Kedokteran.

Ed IV. Jakarta : Media Aeskulapius. Hal. 180-184 Eroschenko, Victor P, 2013, diFiore’s Atlas of Histology with Functional Correlations 12 edition,

Wolters Kluwer Health, Philadelphia. Pp. 325-329 Gray H, Drake R, Vogl W, et al, 2010, Gray's Anatomy for Students, Elsevier/Churchill

Livingstone, Philadelphia-United States of America, pp. 226-230.

Goodman, Gilman, 2007, Dasar Farmakologi Terapi, Edisi 10, Penerbit Buku Kedokteran EGC,

Jakarta-Indonesia, hal. 201-222. Guyton AC, Hall JE, 2008, Liver as An Organ, Textbook of Medical Physiology, 11th edn,

Elsevier, Singapore, pp. 902-908. Ismarani, 2012, Potensi Senyawa Tanin dalam Menunjang Produksi Ramah Lingkungan,

CEFARS: Jurnal Agribisnis dan Pengembangan Wilayah, Vol. 3, No.2. hal. 46-55 Istiantoro YH, Setiabudy R, 2009, Tuberkulostatik dan Leprostatik, In: Gunawan SG,

Setiabudy R, Nafriadi, dkk (eds.), Farmakologi dan Terapi FK UI, Edisi 5, Balai Penerbit Fakultas Kedokteran Universitas Indonesia, Jakarta-Indonesia, hal. 613-617.

INSA (Indian National Science Academy), 2000, Guideline For Care and Use Of Animals In Scientific Research, Bengal Offset Works, New Delhi, pp. 14-15.

Kementerian Kesehatan RI, 2014, Pedoman Nasional Pengendalian Tuberkulosis, Jakarta :

Kementrian Kesehatan RI, hal. 21-37 Koolhas, J. M., 2010, The laboratory rat, dalam: The UFAW Handbook on the Care and

Management of Laboratory and Other Research Animals Eighth Edition, University of Groningen, pp. 311-326.

Kumar PS, Ramesh P, 2014, Evaluation of Hepatoprotective Actyvity of Methanolic Stem Bark

Extract of Mangifera indica in Rats, International Journal for Advanced Review and Research in Pharmacy, pp. 129-143.

Kusumowati ITD, Sudjono TA, Suhendi A, Da'i M, Wirawati R, 2012, Korelasi Kandungan

Fenolik dan Aktivitas Antiradikal Ekstrak Etanol Daun Empat Tanaman Obat Indonesia (Piper bettle, Sauropus Androgynus, Averrhoa bilimbi dan Guazuma ulmifolia), Pharmacon, Vol. 13, No. 1, pp. 1-5.

Li T, Chiang JYL, 2006, Rifampicin Induction of CYP3A4 Requires Pregnane X Receptor Cross

Talk with Hepatocyte Nuclear Factor 4 and Coactivators, and Suppression of Small Heterodimer Partner Gene Expression, Drug Metabolism and Disposition, vol.34, pp. 756-764.

Ma X, Idle JR, Gonzales FJ, 2008, The Pregnane X Receptor: From Bench to Bedside, Expert

Opin Drug Metabolisme of Toxicology, vol.4, No. 2, pp. 895- 908. Mardiningsih TL, Sukmana C, Tarigan N, Suriati S, 2012, Efektivitas Insektisida Nabati berbahan

Aktif Azadirahti dan Saponin terhadap Mortalitas dan Intensitas Serangan Aphis gossypii Glover, Bul. Litrro, Vol. 21, No. 2, hal. 171 – 183.

Moore KL, Dalley AF, Agur AMR, 2010, Clinically Oriented Anatomy - 6 ed. Philadelphia,

Wolters Kluwer Health. Pp. 268-274

Nathiya S, Rajaram S, Philips Abraham, 2016, Hesperidin alleviates antitubercular drug induce

doxidative stress, inflammation and apoptosis in rat liver. International Journal of Biomedical Research, vol.7, No. 7, pp. 439- 446

Netter FH, 2011, Atlas of Human Anatomy 5 edition, Philadelphia, Saunders Elsevier. pp 147-151 Notoatmodjo S, 2010, Metodologi Penelitian Kesehatan, Jakarta, Rineka Cipta. Hal 37-38 Paulsen F. & J. Waschke. 2013. Sobotta Atlas Anatomi Manusia : Anatomi Umum dan

Muskuloskeletal. Penerjemah : Brahm U. Penerbit. Jakarta : EGC. pp. 102-119. Porceddu M, Buron N, Roussel C, et al, 2012, Prediction of Liver Injury Induced by Chemicals in

Human with a Multiparametric Assay on Isolated Mouse Liver Mitochondria, Toxicological Sciences, vol.129(2), pp. 332–345.

Pribadi Fajar Wahyu, Dwi Arini Ernawati, 2010, Efek Catechin terhadap Kadar AsamUrat, C–

Reactive Protein(Crp) dan Malondialdehid Darah Tikus Putih (Rattus Norvegicus)

Hiperurisemia, Mandala of Health. Volume 4, Nomor 1. Hal. 39-46. Putri Novitasari, Sri Anna Marliyati, Evy Damayanthi, 2016, Efek Intervensi Buah Takokak

(Solanum Torvum Swartz) Terhadap Kadar Superoksida Dismutase Eritrosit dan 8-Isoprostan Serum pada Wanita Dewasa Gemuk, Jurnal Gizi Pangan, vol.11, No.2, hal: 107-114.

Ramamurthy CH, Subastri A, Suyavaran A, Subbaiah KCV, Valluru L, Thirunavukkarasu C, 2016,

Solanum torvum Swartz. Fruit Attenuates Cadnium-Induced Liver and Kidney Damage Through Modulation of Oxidative Stress and Glycosylation, Springer-Verlag Berlin Heidelberg, Volume 23, Issue 8, pp 7919–7929.

Rompas RA, Edy HJ, Yudistira A, 2012, Isolasi dan Identifikasi flavonoid dalam Daun Lamun

(Syringgodium Isoetifolium), Program Studi Farmasi FMIPA Unsrat Manado. SEPA (Scottish Environmental Protection Agency), 2009, Burial of Small Quantities of Rodent

Carcasses Poisoned on Farmland, National West Policy unit, pp.1-2. Septiana AT, Asnani A, 2012, Kajian Sifat Fisikokimia Esktrak Rumput Laut Coklat Sargassum

duplicatum Menggunakan berbagai Pelarut dan Metode Ekstraksi, Agrointek Volume 6, No. 1. Hal. 22-28.

Setiawan B, Suhartono E, 2007, Peroksidasi Lipid dan Penyakit Terkait Stres Oksidatif pada Bayi

Prematur, Majalah Kedokteran Indonesia, vol.57, no.1, hal. 10-14. Setiawati A, Suyatna FD, Gan S, 2009, Pengantar Farmakologi, In: Gunawan SG, Setiabudy R,

Nafriadi, dkk (eds.), Farmakologi dan Terapi FK UI, Edisi 5, Balai Penerbit Fakultas Kedokteran Universitas Indonesia, JakartaIndonesia, hal. 8-10.

Sherwood, Lauralee, 2012, Fisiologi Manusia dari Sel ke Sistem, Jakarta, EGC. Hal. 615- 616 Sirait N, 2009, Terong Cepoka (Solanum torvum) Herba yang Berkhasiat sebagai Obat, Warta

Penelitian dan Pengembangan Tanaman Industri, Volume 15, Nomor 3. Hal 10-11. Siswonoto S, 2008, Hubungan Kadar Malondialdehid Plasma dengan Keluaran Klinis Stroke

Iskemik Akut, Thesis, Program Pasca Sarjana Magister Ilmu Biomedik dan PPDS Ilmu Penyakit Saraf, Universitas Diponegoro, Semarang-Indonesia. Hal 46-52.

Sivapriya M, Dinesha R, Harsha R, Gowda SST, Srinivas L. Antibacterial Activity of Different

Extracts of Sundakai (Solanum torvum) Fruit Coat. Int J Biol Chem. 2011; 5 (1): 1-5. Soewandhi SN, Kosasih, Mauludin R, et al, 2007, Pengaruh Energi Mekanik dan Termik

Terhadap Senyawa Rifampisin, Majalah Farmasi Indonesia, vol.18(3), hal.124–132. Suarsana IN, Utama IH, Agung IG, dkk, 2011, Pengaruh Hiperglikemia dan Vitamin E pada

Kadar Malondialdehida dan Enzim Antioksidan Intrasel Jaringan Pankreas Tikus, MKB, vol.43, no.2, hal.72-76.

Sulistyaningrum E, Pribadi FW, 2010, Pengaruh Pemberian Suspensi Meniran (Phyllanthus niruri

L.) terhadap Kerusakan Hepar Tikus Putih yang diinduksi Antituberkulosis Rifampisin dan Isoniazid dalam Jurnal Mandala of Health Volume 4, No. 1, Purwokerto, Universitas Jendral Soedirman. Hal. 1-7.

Sumardika, IW., Jawi, IM, 2012, Ekstrak air daun ubi jalar ungu memperbaiki profil lipid dan meningkatkan kadar SOD darah tikus yang diberi makanan tinggi kolestrol, Medicina, vol.43, pp. 67-71.

Tayal V, Kalra BS, Agarwal S, et al, 2007, Hepatoprotective Effect of Tocopherol Against Isoniazid and Rifampicin Induced Hepatotoxicity in Albino Rabbits, Indian Journal of Experimental Biology, vol.45, pp.1031-1036.

Yousaf Z, Wang Y, Baydoun E, 2013, Phytochemistry and Pharmacological Studies on Solanum

torvum Swartz, Journal of Applied Pharmaceutical Science Vol. 3 (04), pp. 152-160. Yustika AR, Aulanni’am, Prasetyawan S, 2013, Kadar Malondialdehida (MDA) dan Gambaran

Histologi pada Ginjal Tikus Putih (Rattus novergicus) Pasca Induksi Cylosprine-A, Kimia Student Journal, vol.1, no.2, hal. 222- 228.

Zainuri M, Wanandi SI, 2012, Aktivitas Spesifik Manganese Superoxide Dismutase (MnSOD) dan

Katalase Pada Hati Tikus yang Diinduksi Hipoksia Sistemik: Hubungannya Dengan Kerusakan Oksidatif, Media Litbang Kesehatan, vol.22, no.2, hal. 87-92.